U01 Stock Overview
Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 1/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
My Notes
Capture your thoughts, links and company narrative
Delivra Health Brands Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.0035 |
52 Week High | CA$0.036 |
52 Week Low | CA$0.0015 |
Beta | 1.03 |
1 Month Change | 0% |
3 Month Change | -58.82% |
1 Year Change | -46.15% |
3 Year Change | -89.58% |
5 Year Change | -96.31% |
Change since IPO | -99.02% |
Recent News & Updates
Recent updates
Shareholder Returns
U01 | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | -46.2% | 3.4% | 2.0% |
1Y | -46.2% | -14.7% | 9.6% |
Return vs Industry: U01 underperformed the German Pharmaceuticals industry which returned -14.7% over the past year.
Return vs Market: U01 underperformed the German Market which returned 9.6% over the past year.
Price Volatility
U01 volatility | |
---|---|
U01 Average Weekly Movement | 117.5% |
Pharmaceuticals Industry Average Movement | 5.6% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 11.7% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: U01's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: U01's weekly volatility has increased from 79% to 117% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Gord Davey | delivrahealthbrands.com |
Delivra Health Brands Inc., through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide. The company offers cannabis, liquid sleep shots, sleep powder packets, gummies, and pain relief creams. It sells its products under LivRelief, Dream Water, and LivRelief infused brands.
Delivra Health Brands Inc. Fundamentals Summary
U01 fundamental statistics | |
---|---|
Market cap | €3.16m |
Earnings (TTM) | €115.93k |
Revenue (TTM) | €8.00m |
27.3x
P/E Ratio0.4x
P/S RatioIs U01 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
U01 income statement (TTM) | |
---|---|
Revenue | CA$11.87m |
Cost of Revenue | CA$5.80m |
Gross Profit | CA$6.08m |
Other Expenses | CA$5.90m |
Earnings | CA$172.00k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.00055 |
Gross Margin | 51.18% |
Net Profit Margin | 1.45% |
Debt/Equity Ratio | 44.3% |
How did U01 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/08 02:04 |
End of Day Share Price | 2025/01/08 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Delivra Health Brands Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Siddharth Rajeev | Fundamental Research Corp. |
Neal Gilmer | Haywood Securities Inc. |
Greg McLeish | Research Capital Corporation |